InvestorsHub Logo
icon url

kylelele

06/21/13 8:14 AM

#47626 RE: bgrass1 #47625

bgrass, as a large shareholder on this board, I'm curious of your opinion. Lets say hypothetically that sales are large enough that they can sustain operation with the incoming revenue. However, not large enough to fund a signicant advertisement campaign for growth. In this scenario, would you rather them dilute further to allow a TV advertising campaign utilizing our athletes, or do neither? Thanks!
icon url

scooter28

06/21/13 8:36 AM

#47630 RE: bgrass1 #47625

if the pharma angle is all hogwash grass, you can kiss your shares goodby. no way Fuse generates the revs against mounting huge costs with the three products they have now. the only way would be for the three items to catch on and get re-ordered like crazy. I have seen nothing at anytime in the last two years that leads me to believe this will happen. I do not recall one time on this board when fast-rising costs were addressed in relationship to all these revs that we are supposed to get. The roll-out to Walgreen's will give a nice shot in the arm rev-wise, as will the second roll-out to the mystery client, but all the while, mounting costs will have to be more than offset by reorder revs and new customers. If we had the funds to accomplish all this, then maybe we could get to strong positive cash flow, but alas, we don't. Better hold out for pharma or a military contract.
icon url

StockdungU

06/21/13 10:11 AM

#47645 RE: bgrass1 #47625

FUSE should hire the Thong Lady for ads. Sex sells better that golfer who at one time was chased down driveway by ex-wife with golf club because he cheated on her by hiring expensive Hookers.